Clinico-pathological correlation in case of BRAT1 mutation

10Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

The clinical picture of BRCA1-associated protein required for ATM activation-1 (BRAT1) comprises retractable early-onset epileptic encephalopathy, progressive microcephaly, and early demise. Both, inter- and intrafamilial variations of features of BRAT1-associated disease have been described. Here, the familial case of a brother and sister with homozygous pathogenic variants in BRAT1 is presented with special emphasis on differences in seizure type/onset and central nervous system lesions. The neuropathology is extensively discussed and hypotheses put forward that may shed light on etiology of brain symptomatology within the context of BRAT1 mutations.

Cite

CITATION STYLE

APA

Szymańska, K., Laure-Kamionowska, M., Szczałuba, K., Koppolu, A., Furmanek, M., Kuśmierska, K., … Rydzanicz, M. (2018). Clinico-pathological correlation in case of BRAT1 mutation. Folia Neuropathologica, 56(4), 362–371. https://doi.org/10.5114/fn.2018.80870

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free